NPC: CMS Proposed Rule Hinders Value-Based Arrangements
In a letter to the Centers for Medicare and Medicaid Services, the National Pharmaceutical Council (NPC) outlines some key issues [...]
Report Spotlights NPC’s Webinar on COVID-19 Prices
A recent report by The Pink Sheet spotlights the National Pharmaceutical Council's (NPC) recent meeting on COVID-19 drug prices. The [...]
NPC Spotlights New NPC/Duke-Margolis Health Policy Fellow Salama Freed
A recent National Pharmaceutical Council blog post spotlights Salama Freed, the new NPC/Duke-Margolis Postdoctoral Health Policy fellow. Freed says she [...]
NPC Webinar on COVID-19 Prices Nears
The National Pharmaceutical Council's webinar on COVID-19 drug prices is less than a week away. Registration for the event remains [...]
NPC, Duke-Margolis Center for Health Policy Name New Health Policy Fellow
The National Pharmaceutical Council (NPC) and Duke-Margolis Center for Health Policy recently named Salama Freed as the 2020-22 post-doctoral health [...]
NPC Plans Webinar in Prices for COVID-19 Drugs
An upcoming webinar hosted by the National Pharmaceutical Council (NPC) will discuss a range of pricing-related issues for COVID-19 drugs. [...]
NPC Blog Post Reflects on AMCP’s Format
The National Pharmaceutical Council (NPC) in a recent blog post reflects on the Academy of Managed Care Pharmacy's (AMCP) Format [...]
Dubois: It’s Time to Talk COVID-19 Prices
In a race to develop a vaccine for COVID-19, the biopharmaceutical industry has worked at "unheard-of speed," National Pharmaceutical Council [...]
Study Examines Value-Based Arrangements
A study published earlier this year in Value in Health explores the role of value-based arrangements in the U.S. health [...]
Research Considers Valuation of Indirect Benefits
The National Pharmaceutical Council (NPC) and RTI Health Solutions in research published earlier this year found the inclusion of indirect [...]
Experts: Including Productivity in Value Assessment Frameworks Can Make Difference
The National Pharmaceutical Council (NPC) in a recent study published in JAMA suggests including productivity in value assessments can have [...]
Panel Discusses How Pandemic Might Impact Value of Innovation
A panel discussion during the eyeforpharma Virtual Conference discussed how the pandemic might impact the value of innovation, productivity and [...]
NPC’s Leonard Outlines Findings of Research on Coverage Decisions
National Pharmaceutical Council President and CEO Dan Leonard in a recent write up published on Pharmacy Times outlines some key [...]
Blog Post: Making the Most of Our Health Care Dollars
A recent blog post on Going Below the Surface highlights a panel discussion during AcademyHealth National Health Policy Conference that [...]
NPC Study: Measurement Standards Needed to Assess Direct, Indirect Benefits of Therapies
While therapies capable of mental and physical improvements can see both direct and indirect benefits, measurement standards are necessary to [...]
NPC Webinar to Spotlight Evidence-Based Health Coverage
The National Pharmaceutical Council (NPC) is slated to host a webinar noon EST Feb. 13 highlighting evidence-based coverage decisions by [...]
NPC’s Leonard Outlines ‘Wish List’ for Health Sector
National Pharmaceutical Council President and CEO Dan Leonard in an article published on Chain Drug Review outlines his wish list [...]
SWHR’s Kocsis: Women Matter in Value Assessments
The National Pharmaceutical Council (NPC) recently sat down with the Society for Women's Health Research (SWHR) Vice President of Public [...]
Webinar Spotlights Low-Value Care
A Jan. 15 webinar hosted by the Going Below the Surface Forum, in partnership with AcademyHealth and the National Pharmaceutical [...]
NPC: No ‘Best’ Framework for Value Assessment
The National Pharmaceutical Council (NPC) in a recent report found that out of seven value assessment frameworks, there was no [...]
Drug Pricing Value Assessment Methods in the United States: The National Pharmaceutical Council Viewpoint
Swarali Tadwalkar, MPHIntern Written by Swarali Tadwalkar, MPH, Guest Blogger and Research Intern at HealthEconomics.Com Drug prices are the [...]